The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy. Homo sapiens

Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature Overall design: 136 breast cancer samples that were treated with tamoxifen were classified using the 76-gene signature

利用76基因特征标记（76-gene signature）将他莫昔芬（tamoxifen）治疗的乳腺癌患者划分为高风险组与低风险组。整体实验设计：对136例接受他莫昔芬治疗的乳腺癌样本采用76基因特征标记进行分类。